Silence Therapeutics (SLN) Non-Current Assets (2018 - 2026)

Silence Therapeutics' Non-Current Assets history runs 9 years deep, the most recent figure standing at $12.3 million for Q1 2026.

• In Q1 2026, Non-Current Assets fell 20.87% year-over-year to $12.3 million; the TTM figure through Mar 2026 stood at $12.3 million (down 20.87% YoY), while the FY2025 annual figure was $12.8 million, down 16.27% from the prior year.
• Non-Current Assets came in at $12.3 million for Q1 2026 at Silence Therapeutics, down from $12.8 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $16.7 million in Q2 2025 to a low of $12.3 million in Q1 2026.
• A 5-year average of $14.0 million and a median of $13.2 million in 2025 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets increased 25.26% in 2023 and declined 20.87% in 2026, its largest moves.
• Silence Therapeutics' Non-Current Assets stood at $12.7 million in 2022, then advanced by 25.26% to $15.9 million in 2023, then dropped by 3.9% to $15.3 million in 2024, then slipped by 16.27% to $12.8 million in 2025, then declined by 4.01% to $12.3 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $12.3 million, $12.8 million, and $13.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison